Gene: DNAH5
Official Full Name: dynein axonemal heavy chain 5provided by HGNC
Gene Summary: This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09867 | DNAH5 Knockout cell line (HeLa) | Human | DNAH5 | 1:3~1:6 | Negative | Online Inquiry |
KO09868 | DNAH5 Knockout cell line (HCT 116) | Human | DNAH5 | 1:2~1:4 | Negative | Online Inquiry |
KO09869 | DNAH5 Knockout cell line (A549) | Human | DNAH5 | 1:3~1:4 | Negative | Online Inquiry |
DNAH5 Gene Knockout Cell Lines are genetically modified cell lines created to precisely disrupt the DNAH5 gene, which encodes a critical component of dynein, a motor protein essential for cellular transport and ciliary function. This product is invaluable for understanding the physiological roles of the DNAH5 gene, particularly in relation to motility and organelle positioning in eukaryotic cells. By employing CRISPR/Cas9 gene editing technology, these knockout cell lines effectively demonstrate the consequences of losing DNAH5 function, thereby providing researchers with a powerful tool to investigate gene function and its implications in disease.
The key mechanism by which these cell lines operate involves the targeted deletion of the DNAH5 gene, allowing for the analysis of resultant phenotypic alterations. This knockout model facilitates the exploration of the gene's role in various cellular processes, including ciliary dynamics and motility, which are vital in conditions such as primary ciliary dyskinesia. Understanding these cellular mechanisms opens pathways for potential therapeutic approaches and enhances our comprehension of genetic disorders linked to ciliary dysfunction.
In the realm of scientific research and clinical applications, utilizing DNAH5 Gene Knockout Cell Lines represents a significant advancement. These models are ideal for high-throughput screening, drug discovery, and functional studies aimed at elucidating the pathophysiology of ciliary-related diseases. Compared to conventional models, our knockout cell lines offer greater specificity and reliability, significantly reducing the time needed to derive conclusive results.
For researchers, the ability to study the direct effects of DNAH5 disruption offers unprecedented insights into its biological relevance, thus aiding in the development of targeted therapies and diagnostic tools. Clinicians can also benefit from this knowledge by translating findings into clinical settings, improving patient care through more informed approaches to treatment.
At our company, we pride ourselves on our extensive expertise in cellular and molecular biology, providing researchers with high-quality biological products designed to accelerate scientific discovery. The DNAH5 Gene Knockout Cell Lines exemplify our commitment to delivering innovative solutions that strengthen research capabilities and drive advancements in medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.